{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:21:06Z","timestamp":1787498466658,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,23]]},"DOI":"10.7759\/cureus.115029","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:29:48Z","timestamp":1787495388000},"source":"Crossref","is-referenced-by-count":0,"title":["Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastoma With an Unusual EWSR1::RAD51B Gene Fusion: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Sahar","family":"Al-Mustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Al-Kawaaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litty","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelisa","family":"Franchitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M","family":"Aldape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyas M","family":"Hattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis DN","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al.. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021, 23:1231-51. 10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1905-0","article-title":"Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma","volume":"136","author":"Stichel D","year":"2018","unstructured":"Stichel D, Ebrahimi A, Reuss D, et al.. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma. Acta Neuropathol. 2018, 136:793-803. 10.1007\/s00401-018-1905-0","journal-title":"Acta Neuropathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1913-0","article-title":"cIMPACT-NOW update 3: recommended diagnostic criteria for \"Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV\"","volume":"136","author":"Brat DJ","year":"2018","unstructured":"Brat DJ, Aldape K, Colman H, et al.. cIMPACT-NOW update 3: recommended diagnostic criteria for \"Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV\". Acta Neuropathol. 2018, 136:805-10. 10.1007\/s00401-018-1913-0","journal-title":"Acta Neuropathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.70035","article-title":"cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumors","volume":"36","author":"Wesseling P","year":"2026","unstructured":"Wesseling P, Capper D, Reifenberger G, et al.. cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumors. Brain Pathol. 2026, 36:e70035. 10.1111\/bpa.70035","journal-title":"Brain Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan CW","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A, et al.. The somatic genomic landscape of glioblastoma. Cell. 2013, 155:462-77. 10.1016\/j.cell.2013.09.034","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2734","article-title":"The integrated landscape of driver genomic alterations in glioblastoma","volume":"45","author":"Frattini V","year":"2013","unstructured":"Frattini V, Trifonov V, Chan JM, et al.. The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet. 2013, 45:1141-9. 10.1038\/ng.2734","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper D","year":"2018","unstructured":"Capper D, Jones DT, Sill M, et al.. DNA methylation-based classification of central nervous system tumours. Nature. 2018, 555:469-74. 10.1038\/nature26000","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1879-y","article-title":"Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience","volume":"136","author":"Capper D","year":"2018","unstructured":"Capper D, Stichel D, Sahm F, et al.. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018, 136:181-210. 10.1007\/s00401-018-1879-y","journal-title":"Acta Neuropathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.013.10178","article-title":"Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment","volume":"32","author":"Parker BC","year":"2013","unstructured":"Parker BC, Zhang W. Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment. Chin J Cancer. 2013, 32:594-603. 10.5732\/cjc.013.10178","journal-title":"Chin J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/his.12269","article-title":"The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review","volume":"64","author":"Fisher C","year":"2014","unstructured":"Fisher C. The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review. Histopathology. 2014, 64:134-50. 10.1111\/his.12269","journal-title":"Histopathology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.12.009","article-title":"The biology of Ewing sarcoma","volume":"254","author":"Riggi N","year":"2007","unstructured":"Riggi N, Stamenkovic I. The biology of Ewing sarcoma. Cancer Lett. 2007, 254:1-10. 10.1016\/j.canlet.2006.12.009","journal-title":"Cancer Lett"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22335","article-title":"Gene fusions in soft tissue tumors: recurrent and overlapping pathogenetic themes","volume":"55","author":"Mertens F","year":"2016","unstructured":"Mertens F, Antonescu CR, Mitelman F. Gene fusions in soft tissue tumors: recurrent and overlapping pathogenetic themes. Genes Chromosomes Cancer. 2016, 55:291-310. 10.1002\/gcc.22335","journal-title":"Genes Chromosomes Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf2666","article-title":"An anatomic transcriptional atlas of human glioblastoma","volume":"360","author":"Puchalski RB","year":"2018","unstructured":"Puchalski RB, Shah N, Miller J, et al.. An anatomic transcriptional atlas of human glioblastoma. Science. 2018, 360:660-3. 10.1126\/science.aaf2666","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12900","article-title":"The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature","volume":"31","author":"Lopez-Nunez O","year":"2021","unstructured":"Lopez-Nunez O, Cafferata B, Santi M, et al.. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature. Brain Pathol. 2021, 31:70-83. 10.1111\/bpa.12900","journal-title":"Brain Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12619","article-title":"EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity","volume":"29","author":"Siegfried A","year":"2019","unstructured":"Siegfried A, Rousseau A, Maurage CA, et al.. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity. Brain Pathol. 2019, 29:53-62. 10.1111\/bpa.12619","journal-title":"Brain Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlad076","article-title":"Neuroepithelial tumor with EWSR1::PATZ1 fusion: a literature review","volume":"82","author":"Kim H","year":"2023","unstructured":"Kim H, Lee K, Phi JH, Paek SH, Yun H, Choi SH, Park SH. Neuroepithelial tumor with EWSR1::PATZ1 fusion: a literature review. J Neuropathol Exp Neurol. 2023, 82:934-47. 10.1093\/jnen\/nlad076","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12918","article-title":"Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms","volume":"31","author":"Sloan EA","year":"2021","unstructured":"Sloan EA, Chiang J, Villanueva-Meyer JE, et al.. Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. Brain Pathol. 2021, 31:e12918. 10.1111\/bpa.12918","journal-title":"Brain Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-25-0321","article-title":"Circneil3 stabilizes SPI1 mRNA and promotes glioma progression and temozolomide resistance by binding to U2AF2","volume":"24","author":"Xue Z","year":"2026","unstructured":"Xue Z, Peng Q, Liu Z, Sun S. Circneil3 stabilizes SPI1 mRNA and promotes glioma progression and temozolomide resistance by binding to U2AF2. Mol Cancer Res. 2026, 24:283-92. 10.1158\/1541-7786.MCR-25-0321","journal-title":"Mol Cancer Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1126\/science.8066464","article-title":"Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein","volume":"265","author":"Sung P","year":"1994","unstructured":"Sung P. Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein. Science. 1994, 265:1241-3. 10.1126\/science.8066464","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1997.5062","article-title":"Identification of a novel human RAD51 homolog, RAD51B","volume":"46","author":"Albala JS","year":"1997","unstructured":"Albala JS, Thelen MP, Prange C, Fan W, Christensen M, Thompson LH, Lennon GG. Identification of a novel human RAD51 homolog, RAD51B. Genomics. 1997, 46:476-9. 10.1006\/geno.1997.5062","journal-title":"Genomics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1998.5226","article-title":"Identification, characterization, and genetic mapping of Rad51d, a new mouse and human RAD51\/RecA-related gene","volume":"49","author":"Pittman DL","year":"1998","unstructured":"Pittman DL, Weinberg LR, Schimenti JC. Identification, characterization, and genetic mapping of Rad51d, a new mouse and human RAD51\/RecA-related gene. Genomics. 1998, 49:103-11. 10.1006\/geno.1998.5226","journal-title":"Genomics"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000389","article-title":"Dichotomy of genetic abnormalities in PEComas with therapeutic implications","volume":"39","author":"Agaram NP","year":"2015","unstructured":"Agaram NP, Sung YS, Zhang L, et al.. Dichotomy of genetic abnormalities in PEComas with therapeutic implications. Am J Surg Pathol. 2015, 39:813-25. 10.1097\/PAS.0000000000000389","journal-title":"Am J Surg Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001119","article-title":"Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors","volume":"42","author":"Bennett JA","year":"2018","unstructured":"Bennett JA, Braga AC, Pinto A, et al.. Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors. Am J Surg Pathol. 2018, 42:1370-83. 10.1097\/PAS.0000000000001119","journal-title":"Am J Surg Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100402","article-title":"Sarcomas with RAD51B fusions are associated with a heterogeneous phenotype","volume":"37","author":"Chang HY","year":"2024","unstructured":"Chang HY, Dermawan J, Sharma A, et al.. Sarcomas with RAD51B fusions are associated with a heterogeneous phenotype. Mod Pathol. 2024, 37:100402. 10.1016\/j.modpat.2023.100402","journal-title":"Mod Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01059","article-title":"Rano 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults","volume":"41","author":"Wen PY","year":"2023","unstructured":"Wen PY, van den Bent M, Youssef G, et al.. Rano 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol. 2023, 41:5187-99. 10.1200\/JCO.23.01059","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03100-8","article-title":"Identification of a RAD51B enhancer variant for susceptibility and progression to glioma","volume":"23","author":"Huang L","year":"2023","unstructured":"Huang L, Xu W, Yan D, Shi X, Zhang S, Chen M, Dai L. Identification of a RAD51B enhancer variant for susceptibility and progression to glioma. Cancer Cell Int. 2023, 23:246. 10.1186\/s12935-023-03100-8","journal-title":"Cancer Cell Int"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041003","article-title":"PARP inhibitors in glioma: a review of therapeutic opportunities","volume":"14","author":"Sim HW","year":"2022","unstructured":"Sim HW, Galanis E, Khasraw M. PARP inhibitors in glioma: a review of therapeutic opportunities. Cancers (Basel). 2022, 14:1003. 10.3390\/cancers14041003","journal-title":"Cancers (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/518751-isocitrate-dehydrogenase-idh-wildtype-glioblastoma-with-an-unusual-ewsr1rad51b-gene-fusion-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:29:49Z","timestamp":1787495389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/518751-isocitrate-dehydrogenase-idh-wildtype-glioblastoma-with-an-unusual-ewsr1rad51b-gene-fusion-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.115029","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}